Delivery Order SPE2DB24D1205-SPE2DB25FCWAW
- Not listed
- The Defense Logistics Agency awarded a $7,575.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Imbruvica 70 mg capsules (28-count packaging) with a completion date of June 24, 2025. This non-set-aside, competitively awarded contract is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $16,233.74 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on September 3, 2025, with an ultimate completion date of September 24, 2025. This firm fixed-price, competitively awarded delivery order was placed without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Imbruvica 70 mg capsules (28-count units) with a contract value of $7,575.75. This is a firm fixed-price delivery order with an ultimate completion date of August 20, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The award was made through open competition with no set-aside designation, and the place of performance is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of IMBRUVICA 140 mg capsules (90-count units) with a ceiling value of $16,233.74. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 10, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor based in Conshohocken, Pennsylvania, received a $8,116.87 delivery order award from the Defense Logistics Agency on September 10, 2025, for IMBRUVICA 140 mg capsules (90-count supply). The contract operates under firm fixed-price terms with an ultimate completion date of October 1, 2025, and was awarded competitively with no set-aside designation. This delivery order is a child contract issued against AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) under a firm fixed-price contract. This delivery order, issued on August 15, 2025, with an ultimate completion date of September 8, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract utilizes a delivery order mechanism,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,575.75 for IMBRUVICA 140 mg tablets (28-count supply) on August 28, 2025, with completion scheduled for September 19, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and is being performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Imbruvica 140 mg capsules (90-count units) with a ceiling value of $8,116.87. This firm fixed-price delivery order, which is not set-aside and competitively awarded, is scheduled for completion by September 12, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This award represents a continuation of AmerisourceBergen's...
- The Defense Logistics Agency awarded a $7,575.75 delivery order to AmerisourceBergen Drug Corp for IMBRUVICA 70 mg capsules (28-count) on August 28, 2025, with a completion date of September 19, 2025. This non-set-aside contract uses firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and running through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Imbruvica 420 mg tablets (28-count units) valued at $53,030.25 with a firm fixed price structure. The order is scheduled for completion by September 9, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded contract and is issued under...
- SPE2DB24D1205Indefinite Delivery Contract
- SPE2DB24D1205-SPE2DB25FCWAWDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,116.87 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (90-count units) on April 22, 2025. This firm fixed-price, non-set-aside contract is scheduled for completion by May 13, 2025, with performance at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio of pharmaceutical deliveries to the Defense Logistics Agency and Military Health System. The company's track record with DLA demonstrates capability across a broad spectrum of brand-name and generic medications, vaccines, and specialized medical supplies delivered through competitively awarded contracts with firm fixed pricing. This particular delivery order for Imbruvica, a specialty pharmaceutical used in cancer treatment, reflects the company's role in supporting military and veteran healthcare systems with essential pharmaceutical commodities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 4/22/25 |